Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Strata Critical Medical (SRTA) over the last 6 years, with Q3 2025 value amounting to $33.8 million.

  • Strata Critical Medical's Total Non-Current Liabilities fell 2766.82% to $33.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.8 million, marking a year-over-year decrease of 2766.82%. This contributed to the annual value of $28.9 million for FY2024, which is 4804.42% down from last year.
  • Per Strata Critical Medical's latest filing, its Total Non-Current Liabilities stood at $33.8 million for Q3 2025, which was down 2766.82% from $31.8 million recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Total Non-Current Liabilities ranged from a high of $55.7 million in Q4 2023 and a low of $9.9 million during Q3 2021
  • In the last 5 years, Strata Critical Medical's Total Non-Current Liabilities had a median value of $34.9 million in 2022 and averaged $35.6 million.
  • As far as peak fluctuations go, Strata Critical Medical's Total Non-Current Liabilities surged by 25067.35% in 2022, and later plummeted by 4804.42% in 2024.
  • Strata Critical Medical's Total Non-Current Liabilities (Quarter) stood at $13.2 million in 2021, then soared by 229.06% to $43.5 million in 2022, then increased by 28.14% to $55.7 million in 2023, then crashed by 48.04% to $28.9 million in 2024, then grew by 16.9% to $33.8 million in 2025.
  • Its last three reported values are $33.8 million in Q3 2025, $31.8 million for Q2 2025, and $27.8 million during Q1 2025.